RESUMO
OBJECTIVE: To determine whether the routine use of preimplantation genetic screening (PGS) in "good prognosis" women improves in vitro fertilization (IVF) cycle outcome. DESIGN: Randomized, controlled, prospective clinical study. SETTING: Private infertility clinic. PATIENT(S): Infertile women predicted to have a good prognosis as defined by: age <39 years, normal ovarian reserve, body mass index <30 kg/m(2), presence of ejaculated sperm, normal uterus, Assuntos
Fertilização in vitro
, Diagnóstico Pré-Implantação
, Adulto
, Feminino
, Humanos
, Hibridização in Situ Fluorescente
, Cariotipagem
, Gravidez
, Taxa de Gravidez
, Prognóstico
, Estudos Prospectivos
RESUMO
Routine use of EmbryoGlue did not significantly improve pregnancy or implantation rates in nonselected patients receiving either a day 3 or day 5 embryo transfer compared with standard culture media. Future prospective randomized studies need to be performed to determine whether EmbryoGlue is beneficial in a selected patient population.